Aehr Test Systems (NASDAQ: AEHR) is a small-cap stock in the semiconductor industry. Instead of designing or manufacturing chips, the company uses equipment in the chip development process. The company has had a very difficult 2024 overall. Shares are down over 45% in the year as of the close of Dec. 16. All three of its earnings reports showed revenues declining 25% or more compared to the same quarter in 2023.
However, recent AI-related news is exciting investors. Analysts at Craig Hallum are likely feeling much better about the $25 price target they placed on this stock after shares soared nearly 26% on Dec. 16. The research, trading, and investment banking firm’s price target still implies shares could rise 73% from the Dec. 16 closing price.
